Workflow
Non - GAAP measures
icon
Search documents
Veritone, Inc. (VERI) Q4 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha· 2026-03-26 23:25
PresentationI would now like to turn the conference over to Cate Goldsmith, Investor Relations. Please go ahead.Welcome to the Veritone Incorporated Preliminary Unaudited Fourth Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.Cate GoldsmithProsek Partners Limited Thank you, and good afternoon. After the market closed today, Veritone issued a press release announcing its preliminary unaudited financial results for the fourth quarter and full y ...
GigaMedia Announces Fourth-Quarter and Full Year 2025 Financial Results
Prnewswire· 2026-03-26 13:00
GigaMedia Announces Fourth- Quarter and Full Year 2025 Financial Results Accessibility StatementSkip Navigation TAIPEI, March 26, 2026 /PRNewswire/ -- GigaMedia Limited (NASDAQ: GIGM) today announced its unaudited financial results for the fourth quarter and full year of 2025. Highlights For 2025, GigaMedia reported revenues of $3.5 million, with a gross profit of $1.8 million, an operating loss of $3.6 million and the net loss of $1.5 million. The revenues increased by 17.0% in 2025, and the gross prof ...
Waterdrop Inc. (WDH) Q4 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha· 2026-03-25 19:35
PresentationUnknown Executive Good morning, everyone. This is Tracy Li from Waterdrop Investor Relations. It's my pleasure to welcome everyone to Waterdrop's Fourth Quarter and Facial Year 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference call is being recorded. Please note that discussion today will come from forward-looking statements made under the safe harbor provision of the U.S. Private Securities and Litigation Reform Act of 1995. Forward-looking statements are ...
Helios Technologies (NYSE:HLIO) 2026 Earnings Call Presentation
2026-03-20 12:30
INVESTOR DAY M A R C H 2 0 , 2 0 2 6 THE CORE 2030 STRATEGY Powering Progress at the Heart of Motion & Control N Y S E : H L I O AGENDA & BACKGROUND TANIA ALMOND Vice President, Investor Relations & Corporate Communication 2 SAFE HARBOR This presentation and oral statements made by management in connection herewith contain "forward‐looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward‐looking statements involve risks and uncertainties, and actual results may d ...
Mattr Announces Fourth Quarter & Full Year 2025 Results: Enhanced Exposure to North American Wire and Cable Markets Drives Year Over Year Growth
Globenewswire· 2026-03-12 21:01
Core Insights - Mattr Corp. reported strong year-over-year revenue and Adjusted EBITDA growth for both the fourth quarter and the full year of 2025, driven by increased demand in North American wire and cable markets and Composite Technologies' products [2][3] Financial Highlights - Fourth Quarter 2025: - Revenue reached $312.5 million, reflecting a 50.4% increase year-over-year - Operating Income was $13.4 million, up 242.7% year-over-year - Adjusted EBITDA was $31.8 million, a 149.9% increase year-over-year - Net Income from Continuing Operations was $0.8 million, up 103.8% year-over-year - Total Net Loss was $2.0 million, down 84.0% year-over-year - Total Diluted EPS was $(0.03), while diluted Adjusted EPS was $0.04 compared to $(0.20) in the prior year [6][10] - Full Year 2025: - Revenue totaled $1,268.5 million, a 43.3% increase year-over-year - Operating Income was $59.6 million, up 48.5% year-over-year - Adjusted EBITDA reached $154.8 million, a 43.1% increase year-over-year - Net Income from Continuing Operations was $48.3 million, a significant increase of 902.6% year-over-year - Total Net Income was $46.6 million, up 1412.0% year-over-year - Diluted EPS was $0.75, while diluted Adjusted EPS was $0.55 compared to $(0.06) in the prior year [6][10] Segment Performance - Connection Technologies: - Revenue was $190.7 million for Q4 2025, a 117.9% increase year-over-year - Operating Income was $14.8 million, up 288.5% year-over-year - Adjusted EBITDA was $24.2 million, a 143.1% increase year-over-year [14] - Composite Technologies: - Revenue was $121.8 million for Q4 2025, a slight increase of 1.3% year-over-year - Operating Income was $5.7 million, a substantial increase of 1239.9% year-over-year - Adjusted EBITDA was $14.8 million, a 57.1% increase year-over-year [15] Capital Allocation and Outlook - The company plans to maintain a flexible capital allocation strategy, focusing on debt reduction in 2026 due to increased debt from the acquisition of AmerCable [19][21] - Anticipated capital expenditures for 2026 are projected to be between $35 million and $45 million, with a focus on maintenance and high-return growth initiatives [22] - Revenue from Connection Technologies is expected to decline in 2026, while revenue from Composite Technologies is anticipated to increase [22]
KKR (NYSE:KKR) Earnings Call Presentation
2026-03-11 12:00
February 7, 2023 KKR & Co. Inc. Overview Presentation – 4Q'25 March 2026 Legal Disclosures This presentation has been prepared by KKR & Co. Inc. solely for informational purposes for its public stockholders in connection with evaluating the business, operations and financial results of KKR & Co. Inc. and its subsidiaries (collectively, "KKR"), which includes The Global Atlantic Financial Group LLC and its subsidiaries (collectively, "Global Atlantic" or "GA"), unless the context requires otherwise. This pre ...
Quanex Building Products (NX) - 2026 Q1 - Earnings Call Transcript
2026-03-06 17:02
Financial Data and Key Metrics Changes - The company reported net sales of $409.1 million for Q1 2026, an increase of approximately 2.3% compared to $400 million in Q1 2025, primarily due to foreign exchange translation and tariff pass-through [10] - A net loss of $4.1 million or $0.09 per diluted share was reported for Q1 2026, an improvement from a net loss of $14.9 million or $0.32 per diluted share in Q1 2025 [10] - Adjusted EBITDA for Q1 2026 was $27.4 million, down from $38.5 million in the same period last year, mainly due to reduced operating leverage from lower volumes and increased operational costs [11][12] Business Segment Data and Key Metrics Changes - In the Hardware Solutions segment, net sales were $189.1 million for Q1 2026, up 2.4% from $184.7 million in Q1 2025, with volumes down 3.6% and pricing up 0.5% [12] - The Extruded Solutions segment generated revenue of $139.8 million, essentially flat compared to $139.6 million in Q1 2025, with volumes down 2.6% and pricing up slightly by 0.3% [14] - The Custom Solutions segment reported net sales of $89.1 million, representing a growth of 4.8% year-over-year, with volumes up 2.4% and pricing down by 2% [15] Market Data and Key Metrics Changes - Market conditions remain soft, with challenges in global macroeconomic environments impacting results, particularly consumer confidence [4][5] - Economic data from Europe indicates early signs of stabilization and gradual recovery, which is viewed positively for future performance [5] Company Strategy and Development Direction - The company is focused on stabilizing operational performance and strengthening its commercial organization, particularly in the Hardware Solutions segment [6][9] - Initiatives in the Custom Solutions segment aim to support future growth through operational efficiencies and new product development [8] - The company plans to maintain a healthy balance sheet through disciplined debt reduction while pursuing targeted small acquisitions [9] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding demand recovery as consumer confidence is expected to improve over time, despite ongoing macroeconomic challenges [18] - The company anticipates a somewhat flat performance for the first half of 2026 compared to the first half of 2025, with expectations for improved performance in the second half [19] Other Important Information - Cash used by operating activities was $20.2 million for Q1 2026, compared to $12.5 million in Q1 2025, with free cash flow negative at $31.5 million [16] - Liquidity stood at $331.6 million as of January 31, 2026, with a leverage ratio of net debt to last twelve months adjusted EBITDA at 2.8x [17] Q&A Session Summary Question: Performance of the Extruded Solutions segment - Management noted that the Extruded Solutions segment includes historically profitable products, contributing to higher margins [28][29] Question: Revenue growth in the Custom Solutions segment - Management highlighted market share gains in cabinet components due to insourcing and consolidation, driving revenue growth despite a soft market [30][31] Question: Sentiment from the recent Builder Show - Management reported guarded optimism among attendees, with a belief in long-term demand for housing despite current geopolitical and economic uncertainties [33][34] Question: Guidance for margin expansion - Management indicated that the stabilization of the Monterrey plant will drive margin expansion in the second half of 2026 compared to the previous year [43][44] Question: Cash conversion cycle and debt paydown - Management explained that the legacy Tyman business has a longer cash conversion cycle, but improvements are expected over the next few years, with a focus on debt reduction [46][48]
Quanex Building Products (NX) - 2026 Q1 - Earnings Call Transcript
2026-03-06 17:00
Financial Data and Key Metrics Changes - The company reported net sales of $409.1 million for Q1 2026, an increase of approximately 2.3% compared to $400 million in Q1 2025, primarily due to foreign exchange translation and tariff pass-through [10] - A net loss of $4.1 million or $0.09 per diluted share was reported for Q1 2026, an improvement from a net loss of $14.9 million or $0.32 per diluted share in Q1 2025 [10] - Adjusted EBITDA for Q1 2026 was $27.4 million, down from $38.5 million in the same period last year, mainly due to reduced operating leverage from lower volumes and increased operational costs [11][12] Business Segment Data and Key Metrics Changes - In the Hardware Solutions segment, net sales were $189.1 million for Q1 2026, a 2.4% increase from $184.7 million in Q1 2025, with volumes down 3.6% and pricing up 0.5% [12] - The Extruded Solutions segment generated revenue of $139.8 million, essentially flat compared to $139.6 million in Q1 2025, with volumes down 2.6% and pricing up slightly by 0.3% [13] - The Custom Solutions segment reported net sales of $89.1 million, representing a growth of 4.8% year-over-year, with volumes up 2.4% and pricing down by 2% [14] Market Data and Key Metrics Changes - The company noted that market conditions remain soft, with challenges in global macroeconomic environments impacting results, particularly consumer confidence [4][5] - Economic data from Europe indicates early signs of stabilization and gradual recovery, which is viewed positively for future performance [5] Company Strategy and Development Direction - The company is focused on stabilizing operational performance and strengthening its commercial organization, particularly in the Hardware Solutions segment [5][6] - Initiatives in the Custom Solutions segment aim to support future growth through operational efficiencies and new product development [8] - The company plans to maintain a healthy balance sheet through disciplined debt reduction while pursuing targeted small acquisitions [9] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding demand recovery as consumer confidence is expected to improve over time, despite ongoing macroeconomic challenges [18] - The company anticipates a somewhat flat performance for the first half of 2026 compared to the first half of 2025, with expectations for improved performance in the second half [19] Other Important Information - The company expects to generate net sales of $1.84 billion to $1.87 billion for fiscal 2026, with adjusted EBITDA projected at approximately $240 million to $245 million [19] - The liquidity position was reported at $331.6 million as of January 31, 2026, with a leverage ratio of net debt to last twelve months adjusted EBITDA at 2.8x [17] Q&A Session Summary Question: Performance of the Extruded Solutions segment - Management noted that the Extruded Solutions segment includes historically profitable products, contributing to margin improvements [28][29] Question: Revenue growth in the Custom Solutions segment - The revenue growth was attributed to gaining market share as customers insourced products and consolidated facilities, demonstrating value to customers [30][31] Question: Sentiment from the recent Builder Show - The sentiment was described as guarded optimism, with a belief in long-term demand for housing despite current geopolitical and economic uncertainties [32][34] Question: Guidance on margin expansion - Management indicated that margin expansion in the second half of 2026 would be driven by stabilization of the Monterrey plant, which previously impacted EBITDA [43][44] Question: Cash conversion cycle comparison - The legacy Tyman business has a longer cash conversion cycle compared to Quanex, but improvements are expected over the next few years [45][48] Question: Growth potential of spacers in the extruded segment - Demand for spacers is driven by energy performance standards, and management believes it will be a growth driver in 2026 [54][55] Question: Bundling opportunities - Bundling is being developed but has been slow due to the macro backdrop and previous operational issues [57][58] Question: Future of cabinet wood components segment - Management is pleased with the segment's performance and is focused on maximizing shareholder value, though all segments are potentially for sale [59]
CorMedix(CRMD) - 2025 Q4 - Earnings Call Transcript
2026-03-05 14:30
Financial Data and Key Metrics Changes - In Q4 2025, net revenue reached $128.6 million, a significant increase from $31.2 million in Q4 2024, primarily driven by DefenCath's contribution of $91.2 million and Melinta's portfolio contribution of $37.4 million [16][17] - For the full year 2025, total revenue on a pro forma basis was $401.3 million, aligning with previously established guidance [16] - The company reported a net income of $14 million in Q4 2025, impacted by a tax expense of $42.4 million, mostly non-cash [18][19] - Adjusted EBITDA for Q4 was $77.2 million, reflecting modest growth quarter-over-quarter [19] Business Line Data and Key Metrics Changes - DefenCath generated $258.8 million in net sales for the full year 2025 [17] - The operating expenses for Q4 2025 were $48.2 million, up from $17.1 million in the prior year, reflecting the expanded cost structure post-Melinta acquisition [17] Market Data and Key Metrics Changes - The company is focusing on maintaining patient utilization rates for DefenCath in outpatient hemodialysis, especially as reimbursement transitions to a bundled add-on mechanism starting July 1, 2026 [6][7] - The guidance for DefenCath in 2026 is set at $150 million-$170 million, with 2027 guidance at $100 million-$125 million [6][8] Company Strategy and Development Direction - The acquisition of Melinta Therapeutics is seen as a significant growth opportunity, adding durable products like MINOCIN and VABOMERE to the portfolio [11] - The company is actively pursuing discussions with Medicare Advantage providers and new customers for DefenCath, REZZAYO, MINOCIN, and BAXDELA [9] - 2026 is expected to be a transitional year, with a focus on new catalysts and value drivers, particularly the phase 3 ReSPECT data for REZZAYO [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the post-TDAPA environment and maintain growth through strategic pricing and customer negotiations [6][23] - The company is optimistic about the potential for increased Medicare provider reimbursement in 2027, which could lead to a higher net selling price [7] Other Important Information - The company has expanded its workforce significantly, growing from approximately 100 to just under 200 employees, to support growth and operational needs [17] - The company has initiated a share repurchase program, indicating confidence in its financial position and future growth prospects [21] Q&A Session Summary Question: Update on dialysis customer conversations and pricing for DefenCath - Management indicated that conversations are progressing well, focusing on preserving patient utilization and negotiating pricing structures for 2026 and beyond [23] Question: Clinical significance of REZZAYO phase 3 data - Management highlighted that the data will guide commercial utility and marketing strategies, with a focus on pathogen data and secondary endpoints [24][25] Question: Developments on TDAPA extension bills and partnerships - Management noted ongoing efforts with legislators and other companies, but timing remains uncertain due to external factors [29][30] Question: Inpatient opportunity with DefenCath and Melinta product growth - Management discussed the current customer mix and potential growth from mid-sized operators, emphasizing the importance of onboarding new customers [33][41]
Holley (HLLY) - 2025 Q4 - Earnings Call Presentation
2026-03-04 13:30
Fourth Quarter and Full Year 2025 Financial Results Call 1 1 Disclaimer Certain statements in this presentation may be considered "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward- looking statements generally relate to future events or Holley's future financial or operating performance. For example, projections of future revenue and adjusted EBITDA and other metrics, along with statements regarding ...